Levetiracetam Stadafarma (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, influencing neurotransmitter release and reducing neuronal hyper‑excitability. This modulation stabilizes neuronal firing and helps prevent the spread of epileptic activity throughout the brain.

Dosage is individualized; a qualified prescriber determines the appropriate amount based on the patient’s age, weight, renal function, seizure type, and therapeutic response. Patients should follow the prescribing information and never adjust the dose without medical guidance.

Safety data are limited. The medication should be used during pregnancy or lactation only if the potential benefit justifies the potential risk to the fetus or infant. Clinicians should evaluate each case and discuss alternative therapies when appropriate.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with older agents such as carbamazepine or phenytoin, levetiracetam has a relatively favorable drug‑interaction profile, does not require routine serum level monitoring, and is generally well tolerated. Selection depends on seizure type, comorbidities and physician judgment.

Store the product at ambient temperature below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep the container tightly closed and out of reach of children.

Levetiracetam Stadafarma is taken orally, with or without food, as directed by the prescribing clinician. Tablets should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious adverse reactions can include severe allergic responses such as Stevens‑Johnson syndrome, life‑threatening skin reactions, suicidal thoughts or behaviors, and marked mood changes. Immediate medical attention is required if any of these symptoms appear.

Patients with known hypersensitivity to levetiracetam or any excipients should avoid the product. Caution is also advised for individuals with severe renal impairment, uncontrolled psychiatric conditions, or those taking medications listed as major interactions.